SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001616824-24-000009
Filing Date
2024-01-16
Accepted
2024-01-16 17:24:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 bml13g.htm SC 13G 53055
  Complete submission text file 0001616824-24-000009.txt   54596
Mailing Address 156 S. FIRST STREET ZIONSVILLE IN 46077
Business Address 156 S. FIRST STREET ZIONSVILLE IN 46077 317-344-6689
BML Investment Partners, L.P. (Filed by) CIK: 0001373604 (see all company filings)

IRS No.: 383708345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 701 LEE ROAD SUITE 103 WAYNE PA 19087
Business Address 701 LEE ROAD SUITE 103 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Subject) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89137 | Film No.: 24536106
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)